Abstract

Monitoring Of Breast Cancer Treatment Response By Analysis Of Breast Cancer-Derived Extracellular Vesicles

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P2-08-16: The cross-talk between nuclear p-ser294-FOXO3a and cytoplasmic MMP-2 in breast cancer survival and treatment response
Sheau-Fang Yang ... Yu-Chun Huang
Cancer Research | VOL. 82
Sheau-Fang Yang, et. al.Sheau-Fang Yang ... Yu-Chun Huang
15 Feb 2022
Abstract 3152: Breast cancer-derived extracellular vesicles: clinical and prognostic impact
Sabine Kasimir-Bauer ... Oliver Hoffmann
Cancer Research | VOL. 76
Sabine Kasimir-Bauer, et. al.Sabine Kasimir-Bauer ... Oliver Hoffmann
15 Jul 2016
Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer
Ruo-Kai Lin ... Yun-Ru Liu
Molecular Medicine | VOL. 28
Ruo-Kai Lin, et. al.Ruo-Kai Lin ... Yun-Ru Liu
17 Jun 2022
Molecular imaging as biomarker for treatment response and outcome in breast cancer.
Carolina P Schröder ... Jasper J L Van Geel
Therapeutic advances in medical oncology | VOL. 15
Carolina P Schröder, et. al.Carolina P Schröder ... Jasper J L Van Geel
01 Jan 2023
View more papers

More From: The Breast

Paper Title
Journal
Date
Author
Editorial Board
-
The Breast | VOL. -
--
01 Jun 2024
Diagnostic accuracy of intraoperative methods for margin assessment in breast cancer surgery: A systematic review & meta-analysis
Gavin P Dowling ... Arnold D.K Hill
The Breast | VOL. 76
Gavin P Dowling, et. al.Gavin P Dowling ... Arnold D.K Hill
10 May 2024
Impact of neoadjuvant compared to adjuvant chemotherapy on prognosis in patients with hormone-receptor positive / HER2-negative breast cancer: A propensity score matching population-based study
Servah Hosseini-Mellner ... Antonis Valachis
The Breast | VOL. 76
Servah Hosseini-Mellner, et. al.Servah Hosseini-Mellner ... Antonis Valachis
09 May 2024
Screening optimal candidates with operable, early-stage triple-negative breast cancer benefitting from capecitabine maintenance: A post-hoc analysis of the SYSUCC-001 study
Fangfang Duan ... Yuanyuan Huang
The Breast | VOL. 76
Fangfang Duan, et. al.Fangfang Duan ... Yuanyuan Huang
06 May 2024
View more papers